{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:02:30Z","timestamp":1785934950420,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1124\/jpet.104.067140","type":"journal-article","created":{"date-parts":[[2004,8,21]],"date-time":"2004-08-21T05:57:29Z","timestamp":1093067849000},"page":"1255-1265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland"],"prefix":"10.1016","volume":"310","author":[{"given":"Carl P.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Nahorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A. John","family":"Challiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.067140_bib1","doi-asserted-by":"crossref","unstructured":"Adem A and Karlsson E (1997) Muscarinic receptor subtype selective toxins. Life Sci 60: 1069-1076.","DOI":"10.1016\/S0024-3205(97)00049-0"},{"key":"10.1124\/jpet.104.067140_bib2","doi-asserted-by":"crossref","unstructured":"Andersson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45: 253-308.","DOI":"10.1016\/S0031-6997(25)00442-9"},{"key":"10.1124\/jpet.104.067140_bib3","doi-asserted-by":"crossref","unstructured":"Angers S, Salahpoou A, and Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42: 409-435.","DOI":"10.1146\/annurev.pharmtox.42.091701.082314"},{"key":"10.1124\/jpet.104.067140_bib4","doi-asserted-by":"crossref","unstructured":"Armour SL, Foord S, Kenakin T, and Chen WJ (1999) Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. J Pharmacol Toxicol Methods 42: 217-224.","DOI":"10.1016\/S1056-8719(00)00074-5"},{"key":"10.1124\/jpet.104.067140_bib5","doi-asserted-by":"crossref","unstructured":"Batty IH, Carter AN, Challiss RAJ, and Hawthorne JN (1997) Receptor-linked phosphoinositide metabolism, in Neurochemistry\u2014A Practical Guide, 2nd ed, Turner AJ and Bachelard), pp 229-268, IRL Press, Oxford.","DOI":"10.1093\/oso\/9780199634408.003.0008"},{"key":"10.1124\/jpet.104.067140_bib6","doi-asserted-by":"crossref","unstructured":"Brown BL, Albano JD, Ekins RP, Sgherzi AM, and Tampion W (1971) A simple and sensitive saturation assay method for the measurement of adenosine 3\u2032:5\u2032-cyclic monophosphate. Biochem J 121: 561-562.","DOI":"10.1042\/bj1210561"},{"key":"10.1124\/jpet.104.067140_bib7","doi-asserted-by":"crossref","unstructured":"Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, and Felder CC (2003) Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis and pilocarpine-induced seizure activity. Eur J Neurosci 17: 1403-1410.","DOI":"10.1046\/j.1460-9568.2003.02588.x"},{"key":"10.1124\/jpet.104.067140_bib8","doi-asserted-by":"crossref","unstructured":"Caulfield MP and Birdsall NJM (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279-290.","DOI":"10.1016\/S0031-6997(24)01362-0"},{"key":"10.1124\/jpet.104.067140_bib9","doi-asserted-by":"crossref","unstructured":"Chess-Williams R, Chapple CR, Yamanishi T, Yasuda K, and Sellers DJ (2001) The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. J Auton Pharmacol 21: 243-248.","DOI":"10.1046\/j.1365-2680.2001.00231.x"},{"key":"10.1124\/jpet.104.067140_bib10","unstructured":"Clarke NP, Smith K, Napier CM, and Gupta P (2003) Characterisation of muscarinic receptor expression in dog submandibular gland. Br J Pharmacol 138: 123P."},{"key":"10.1124\/jpet.104.067140_bib11","doi-asserted-by":"crossref","unstructured":"Craig DA (1993) The Cheng-Prusoff relationship: something lost in the translation. Trends Pharmacol Sci 14: 89-91.","DOI":"10.1016\/0165-6147(93)90070-Z"},{"key":"10.1124\/jpet.104.067140_bib12","doi-asserted-by":"crossref","unstructured":"Eglen RM, Hegde SS, and Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48: 531-565.","DOI":"10.1016\/S0031-6997(25)06957-1"},{"key":"10.1124\/jpet.104.067140_bib13","doi-asserted-by":"crossref","unstructured":"Eglen RM, Michel AD, Montgomery WW, Kunysz EA, Machado CA, and Whiting RL (1990) The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro. Br J Pharmacol 99: 637-642.","DOI":"10.1111\/j.1476-5381.1990.tb12983.x"},{"key":"10.1124\/jpet.104.067140_bib14","doi-asserted-by":"crossref","unstructured":"Ehlert FJ (2003) Contractile role of M2 and M3 muscarinic receptors in gastrointestinal, airway and urinary bladder smooth muscle. Life Sci 74: 355-366.","DOI":"10.1016\/j.lfs.2003.09.023"},{"key":"10.1124\/jpet.104.067140_bib15","doi-asserted-by":"crossref","unstructured":"Gillberg PG, Sundquist S, and Nilvebrant L (1998) Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Eur J Pharmacol 349: 285-292.","DOI":"10.1016\/S0014-2999(98)00214-3"},{"key":"10.1124\/jpet.104.067140_bib16","doi-asserted-by":"crossref","unstructured":"Gupta P, Anderson CWP, Carter AJ, Casey JH, and Newgreen DT (2002) In vivo bladder selectivity of darifenacin, a new M3 antimuscarinic agent, in the anaesthetised dog. Eur Urol Suppl 1: 515.","DOI":"10.1016\/S1569-9056(02)80508-5"},{"key":"10.1124\/jpet.104.067140_bib17","doi-asserted-by":"crossref","unstructured":"Harriss DR, Marsh KA, Birmingham AT, and Hill SJ (1995) Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol 154: 1241-1245.","DOI":"10.1016\/S0022-5347(01)67039-3"},{"key":"10.1124\/jpet.104.067140_bib18","doi-asserted-by":"crossref","unstructured":"Ikeda K, Kobayashi S, Suzuki M, Miyata K, Takeuchi M, Yamada T, and Honda K (2002) M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 366: 97-103.","DOI":"10.1007\/s00210-002-0554-x"},{"key":"10.1124\/jpet.104.067140_bib19","doi-asserted-by":"crossref","unstructured":"Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature (Lond) 399: 697-700.","DOI":"10.1038\/21441"},{"key":"10.1124\/jpet.104.067140_bib20","doi-asserted-by":"crossref","unstructured":"Kenakin T (2003) Predicting therapeutic value in the lead optimization phase of drug discovery. Nat Rev Drug Discov 2: 429-438.","DOI":"10.1038\/nrd1110"},{"key":"10.1124\/jpet.104.067140_bib21","doi-asserted-by":"crossref","unstructured":"Laniyonu A, Sliwinski-Lis E, and Fleming N (1990) Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells. Eur J Pharmacol 188: 171-174.","DOI":"10.1016\/0922-4106(90)90052-Y"},{"key":"10.1124\/jpet.104.067140_bib22","doi-asserted-by":"crossref","unstructured":"Lazareno S and Birdsall NJ (1993) Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br J Pharmacol 109: 1110-1119.","DOI":"10.1111\/j.1476-5381.1993.tb13737.x"},{"key":"10.1124\/jpet.104.067140_bib23","doi-asserted-by":"crossref","unstructured":"Longhurst PA, Leggett RE, and Briscoe JA (1995) Characterization of the functional muscarinic receptors in the rat urinary bladder. Br J Pharmacol 116: 2279-2285.","DOI":"10.1111\/j.1476-5381.1995.tb15065.x"},{"key":"10.1124\/jpet.104.067140_bib24","doi-asserted-by":"crossref","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"10.1124\/jpet.104.067140_bib25","doi-asserted-by":"crossref","unstructured":"Malone-Lee J, Shaffu B, Anand C, and Powell C (2001) Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial. J Urol 165: 1452-1456.","DOI":"10.1016\/S0022-5347(05)66326-4"},{"key":"10.1124\/jpet.104.067140_bib26","doi-asserted-by":"crossref","unstructured":"Meloy TD, Daniels DV, Hegde SS, Eglen RM, and Ford AP (2001) Functional characterization of rat submaxillary gland muscarinic receptors using microphysiometry. Br J Pharmacol 132: 1606-1614.","DOI":"10.1038\/sj.bjp.0703971"},{"key":"10.1124\/jpet.104.067140_bib27","doi-asserted-by":"crossref","unstructured":"Moriya H, Takagi Y, Nakanishi T, Hayashi M, Tani T, and Hirotsu I (1999) Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci 64: 2351-2358.","DOI":"10.1016\/S0024-3205(99)00188-5"},{"key":"10.1124\/jpet.104.067140_bib28","unstructured":"Nelson CP, Gupta P, Napier CM, and Challiss RAJ (2002) Affinity estimates for darifenacin, tolterodine and oxybutynin at M2 and M3 muscarinic receptors in membrane and intact Chinese hamster ovary cell preparations. Br J Pharmacol 135: 341P."},{"key":"10.1124\/jpet.104.067140_bib29","unstructured":"Newgreen DT and Naylor AM (1996) Comparison of the functional muscarinic receptor selectivity of darifenacin with tolterodine and oxybutynin. Br J Pharmacol 117: 107P."},{"key":"10.1124\/jpet.104.067140_bib30","doi-asserted-by":"crossref","unstructured":"Nilvebrant L, Andersson KE, Gillberg PG, Stahl M, and Sparf B (1997) Tolterodine\u2014a new bladder-selective antimuscarinic agent. Eur J Pharmacol 327: 195-207.","DOI":"10.1016\/S0014-2999(97)89661-6"},{"key":"10.1124\/jpet.104.067140_bib31","unstructured":"Wada Y, Yoshida M, Kitani K, Kikukawa H, Ichinose A, Takahashi W, Gotoh S, Inadome A, Machida J, and Ueda S (1995) Comparison of the effects of various anticholinergic drugs on human isolated urinary bladder. Arch Int Pharmacodyn Ther 330: 76-89."},{"key":"10.1124\/jpet.104.067140_bib32","doi-asserted-by":"crossref","unstructured":"Waldeck K, Larsson B, and Andersson KE (1997) Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland. J Urol 157: 1093-1097.","DOI":"10.1016\/S0022-5347(01)65148-6"},{"key":"10.1124\/jpet.104.067140_bib33","doi-asserted-by":"crossref","unstructured":"Wallis RM and Napier CM (1999) Muscarinic antagonists in development for disorders of smooth muscle function. Life Sci 64: 395-401.","DOI":"10.1016\/S0024-3205(98)00585-2"},{"key":"10.1124\/jpet.104.067140_bib34","doi-asserted-by":"crossref","unstructured":"Wang P, Luthin GR, and Ruggieri MR (1995) Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther 273: 959-966.","DOI":"10.1016\/S0022-3565(25)09628-4"},{"key":"10.1124\/jpet.104.067140_bib35","doi-asserted-by":"crossref","unstructured":"Watson EL, Abel PW, Dijulio D, Zeng W, Makoid M, Jacobson KL, Potter LT, and Dowd FJ (1996) Identification of muscarinic receptor subtypes in mouse parotid gland. Am J Physiol 271: C905-C913.","DOI":"10.1152\/ajpcell.1996.271.3.C905"},{"key":"10.1124\/jpet.104.067140_bib36","doi-asserted-by":"crossref","unstructured":"Watson N, Reddy H, Stefanich E, and Eglen RM (1995) Characterization of the interaction of zamifenacin at muscarinic receptors in vitro. Eur J Pharmacol 285: 135-142.","DOI":"10.1016\/0014-2999(95)00394-Z"},{"key":"10.1124\/jpet.104.067140_bib37","doi-asserted-by":"crossref","unstructured":"Wreggett KA and Wells JW (1995) Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem 270: 22488-22499.","DOI":"10.1074\/jbc.270.38.22488"},{"key":"10.1124\/jpet.104.067140_bib38","doi-asserted-by":"crossref","unstructured":"Wyndaele JJ (2001) The overactive bladder. BJU Int 88: 135-140.","DOI":"10.1046\/j.1464-410x.2001.02296.x"},{"key":"10.1124\/jpet.104.067140_bib39","doi-asserted-by":"crossref","unstructured":"Yamaguchi O, Shishido K, Tamura K, Ogawa T, Fujimura T, and Ohtsuka M (1996) Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle. J Urol 156: 1208-1213.","DOI":"10.1016\/S0022-5347(01)65752-5"},{"key":"10.1124\/jpet.104.067140_bib40","doi-asserted-by":"crossref","unstructured":"Yeomans J, Forster G, and Blaha C (2001) M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68: 2449-2456.","DOI":"10.1016\/S0024-3205(01)01038-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652431554X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652431554X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.067140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:59:28Z","timestamp":1739998768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652431554X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S002235652431554X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.067140","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.067140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}